Re: TASHA - Advancing Remote Patient Monitoring for Diabetic Foot Ulcers: A Patient-Centered Approach application

回复：TASHA - 推进糖尿病足溃疡的远程患者监测：以患者为中心的方法应用

• 批准号: 10089130
• 金额: $ 9.9万
• 依托单位: MEDICAL INTELLIGENCE GROUP LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10089130
• 关键词: Re; TASHA; Advancing; Remote; Patient

Diabetes, the 9th leading cause of death globally and a significant co-morbidity to cardiac-related deaths, poses a major health concern. In the UK alone, over 4 million individuals diagnosed with diabetes face a staggering 23-fold increased risk of developing diabetic foot ulcers (DFUs). Alarmingly, 10% of these DFUs lead to foot amputations, with a mortality rate of 50% within two years. Globally, there are over 450 million diabetics, projected to grow to 578 million by 2030\.To address this urgent issue, Medical Intelligence Group (MIG) offers an innovative three-pillar solution that utilises novel digital and data-enabled tools to more accurately diagnose conditions, stratify patients to appropriate treatments, and increase the application of integrated and multi-modal approaches to determine risk, diagnosis, and predict prognostic outcomes.MIG's solution includes remote monitoring technology, early ulcer detection systems, and AI predictive modelling. By improving ulcer monitoring and enabling timely treatments, MIG's solution significantly improves patient outcomes, relieves stress, and generates cost savings for the NHS. Additionally, the early detection of deteriorating ulcers reduces the need for amputations, benefiting patients both socially and economically.MIG's innovative approach fills an unmet clinical need and addresses the pressing challenge of diabetic foot ulcers. By leveraging novel digital tools, MIG aims to make substantial progress in combating this condition, improving patient well-being, and alleviating the healthcare burden.

糖尿病是全球第9大死亡原因，与心脏有关的死亡的合并症显着，这是一个主要的健康问题。仅在英国，超过400万被诊断患有糖尿病的人面临着惊人的23倍增加糖尿病足溃疡（DFU）的风险。令人震惊的是，这些DFU中有10％导致截肢，死亡率在两年内为50％。在全球范围内，有超过4.5亿糖尿病患者预计到2030年将增长到5.78亿\。诊断状况，将患者分层为适当的治疗，并增加综合和多模式方法的应用，以确定风险，诊断和预测预后结果。MIG的解决方案包括远程监测技术，早期的溃疡检测系统和AI预测性建模。通过改善溃疡监测并及时治疗，MIG的解决方案可显着改善患者的预后，减轻压力并为NHS节省成本。此外，早期发现恶化的溃疡减少了对截肢的需求，从而使患者在社会和经济上受益。通过利用新颖的数字工具，MIG旨在在打击这种情况，改善患者福祉和减轻医疗保健负担方面取得重大进展。